Loading...

DP T

DP

EDAP TMS SA

(EDAP)

2025 6-K

Financing Update

2 Apr '26

Quarterly Results Announcement

25 Mar '26

Investor Conference Announc...

18 Mar '26

Board Changes

12 Feb '26

Preliminary Results

12 Jan '26

FDA Clearance Achieved

20 Nov '25

Filing Summary

18 Nov '25

EDAP TMS Q3 Results

6 Nov '25

Filing Overview

9 Sep '25

HIFU Reimbursement Secured

8 Sep '25

Strong Q2 Performance

28 Aug '25

Credit Facility Announcement

26 Aug '25

Reporting Status Change

1 Jul '25

Shareholders Meeting Notice

2 Jun '25

EDAP 6-K Filing

15 May '25

EDAP TMS Earnings

27 Mar '25

Board Appointment

3 Mar '25

Quarterly Sales Surge

13 Jan '25

Board Appointment

10 Jan '25

Positive Study Results

4 Dec '24

EDAP Q3 Results

7 Nov '24

EDAP Financial Results

28 Aug '24

HIFU Study Update

19 Jul '24

Board Appointment

8 Jul '24

Shareholder Meeting Notice

7 Jun '24

Strong Q1 Performance

16 May '24

Financial Results Announcement

27 Mar '24

FDA Breakthrough Designation

4 Mar '24

Management Changes

2 Jan '24

External Links:

SEC

EDAP TMS SA received FDA 510(k) clearance on November 20, 2025, for enhancements to its Focal One Robotic HIFU system, strengthening its market position in prostate cancer therapy. This upgrade introduces advanced ultrasound imaging and optimized user-interface capabilities, demonstrating the company’s commitment to innovation.

AI Assistant

EDAP TMS SA

2025

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.